This sector is headed by Investment Director Peter Dines, who is a specialist in growing businesses in the Life Sciences and Biosciences markets with the team’s key areas of focus including diagnostics, digital health and medical devices.
The overall sector continues to be an attractive area in which to invest as the cost of global health care is predicted to rise to $8.7trillion by 2020 from $7.0trillion in 2015. This cost is driven by improving treatments in therapeutic areas coupled with rising labour costs and increased life expectancy.
The UK continues to be an active life science hub with a high level of new innovations:
The Life Sciences industry employs almost 235,000 people across the UK and generates a combined estimated turnover of £64.0billion
Since 2011 the UK has secured over £7.5billion of inward investment in the sector
Deloitte expects medical technology industry sales to increase from $363.8billion in 2013 to $513.5billion in 2020 and predicts that in vitro diagnostics will be the leading segment
If your business operates in one of these sectors or you are looking for investment, then please do get in touch with the team today by completing this form.
If you would like to see more information about companies in this sector, then visit our portfolio page.